Skip to main content
Enter your keywords
User account menu
Log in
Main navigation
About
History & Impact
Mission & Values
Leadership
Support SWOG
Join SWOG
Policies & Procedures
Careers
Contact Us
The SWOG Network
How We Work
Our Staff
Our Advocates
Our Partners
News & Events
News
SWOG Stories
SWOG Meetings
For Press
Clinical Trials
Biospecimen Submission
Biospecimen Access
Clinical Trials Search
Clinical Research Resources
Frequently Asked Questions
Publications
Institutions
Quality Assurance & Audits
Serious Adverse Events
Training Resources
CRA Workbench
Protocol Workbench
For Patients
Patient & Advocate Voices
Trials Open to Patients
About SWOG Cancer Trials
Joining a Trial
Glossary
Breadcrumb
SWOG
Clinical Trials
SWOG-8816
SWOG clinical trial number
SWOG-8816
Study of 13-cis Retinoic Acid (Accutane) Plus rIFN-A (Roferon-A) in Mycosis Fungoides
Closed
Phase
Accrual
50%
Abbreviated Title
Study of 13-cis Retinoic Acid (Accutane) Plus rIFN-A (Roferon-A) in Mycosis Fungoides
Activated
05/15/1989
Closed
01/01/1993
